Latest Breaking News On - Reference member state - Page 1 : vimarsana.com

Pyros Pharmaceuticals Announces Positive Outcome of the European Decentralised Procedure for Approval of VIGZIP™ (vigabatrin oral solution)

Pyros Pharmaceuticals Announces Positive Outcome of the European Decentralised Procedure for Approval of VIGZIP™ (vigabatrin oral solution)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Edwin urrutiaMichael smithPyros pharmaceuticals incPyros pharmaceuticalsGerman federal institute for drugsDecentralised procedureFinal assessment reportReference member stateGerman federal instituteMedical devicesMember statesChief executive officer

Pyros Pharmaceuticals Announces Positive Outcome of the European Decentralised Procedure for Approva

PARSIPPANY, N.J. (BUSINESS WIRE) Pyros Pharmaceuticals, Inc. (Pyros or the Company), a leader in the development of enhanced specialty pharmaceuticals for rare diseases, announced today the positive outcome of the Decentralised Procedure (DCP) for VIGZIP™ (vigabatrin oral solution) in Europe. This significant mile.

Michael smithEdwin urrutiaPyros pharmaceuticalsPyros pharmaceuticals incGerman federal institute for drugsDecentralised procedureFinal assessment reportReference member stateGerman federal instituteMedical devicesMember statesChief executive officer

Pyros Pharmaceuticals Announces Positive Outcome of the European Decentralised Procedure for Approval of VIGZIP™ (vigabatrin oral solution)

Pyros Pharmaceuticals Announces Positive Outcome of the European Decentralised Procedure for Approval of VIGZIP™ (vigabatrin oral solution)
joplinglobe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from joplinglobe.com Daily Mail and Mail on Sunday newspapers.

United statesEdwin urrutiaMichael smithGerman federal institute for drugsPyros pharmaceuticalsPyros pharmaceuticals incDecentralised procedureFinal assessment reportReference member stateGerman federal instituteMedical devicesMember statesChief executive officerBusiness wire

Form S-1/A Scilex Holding Co

Form S-1/A Scilex Holding Co
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDistrict of columbiaNorth dakotaSan diegoStanford universityNew yorkSouth africaCayman islandsEteläuomen läiPalo altoHong kongSan francisco bayMonte carloTel avivUnited kingdomState of california

Ipsen : delivers encouraging sales growth in the first quarter of 2021 despite the pandemic, and confirms its full-year guidance

Paris , 22 April 2021 - Ipsen , a global specialty-driven biopharmaceutical group, publishes its sales performance for the first quarter of 2021: Q1 2021 sales summary . | June 16, 2023

France generalIpsen euronextDavid loewEuropean commissionFusion pharmaceuticals incSpecialty careConsumer healthcareChief executive officerTotal salesReference member stateDecentralized procedureFusion pharmaceuticalsAnnual shareholder meeting